235 related articles for article (PubMed ID: 21628793)
1. JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models.
Ploia C; Antoniou X; Sclip A; Grande V; Cardinetti D; Colombo A; Canu N; Benussi L; Ghidoni R; Forloni G; Borsello T
J Alzheimers Dis; 2011; 26(2):315-29. PubMed ID: 21628793
[TBL] [Abstract][Full Text] [Related]
2. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
3. Microtubule destruction induces tau liberation and its subsequent phosphorylation.
Miyasaka T; Sato S; Tatebayashi Y; Takashima A
FEBS Lett; 2010 Jul; 584(14):3227-32. PubMed ID: 20561519
[TBL] [Abstract][Full Text] [Related]
4. Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice.
Kins S; Kurosinski P; Nitsch RM; Götz J
Am J Pathol; 2003 Sep; 163(3):833-43. PubMed ID: 12937125
[TBL] [Abstract][Full Text] [Related]
5. Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain.
Fujimura M; Usuki F; Sawada M; Takashima A
Neurotoxicology; 2009 Nov; 30(6):1000-7. PubMed ID: 19666049
[TBL] [Abstract][Full Text] [Related]
6. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
7. Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons.
Patil S; Chan C
Neurosci Lett; 2005 Aug; 384(3):288-93. PubMed ID: 15939536
[TBL] [Abstract][Full Text] [Related]
8. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
[TBL] [Abstract][Full Text] [Related]
9. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease.
Treiber-Held S; Distl R; Meske V; Albert F; Ohm TG
J Pathol; 2003 May; 200(1):95-103. PubMed ID: 12692847
[TBL] [Abstract][Full Text] [Related]
10. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
12. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
13. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
14. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.
Puig B; Gómez-Isla T; Ribé E; Cuadrado M; Torrejón-Escribano B; Dalfó E; Ferrer I
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):491-502. PubMed ID: 15488025
[TBL] [Abstract][Full Text] [Related]
15. Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease.
Alvarez-de-la-Rosa M; Silva I; Nilsen J; Pérez MM; García-Segura LM; Avila J; Naftolin F
Ann N Y Acad Sci; 2005 Jun; 1052():210-24. PubMed ID: 16024764
[TBL] [Abstract][Full Text] [Related]
16. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
[TBL] [Abstract][Full Text] [Related]
17. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?
Schnurra I; Bernstein HG; Riederer P; Braunewell KH
Neurobiol Dis; 2001 Oct; 8(5):900-9. PubMed ID: 11592857
[TBL] [Abstract][Full Text] [Related]
18. Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains.
Pearson AG; Byrne UT; MacGibbon GA; Faull RL; Dragunow M
Neurosci Lett; 2006 May; 398(3):246-50. PubMed ID: 16481106
[TBL] [Abstract][Full Text] [Related]
19. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
20. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
